Athersys drug could ‘change the way we do transplants’
Researchers have found that the Athersys stem cell product, MultiStem, has been effective in preventing rejection in organ transplant patients. The drug might someday eliminate the need for transplant recipients to take a life-long regime of immunosuppressant drugs that have potentially detrimental side effects. Athersys has been developing MultiStem for the past six to eight … Continue reading “Athersys drug could ‘change the way we do transplants’”